Yan Liu

<i>EGFR-T790M</i> Is a Rare Lung Cancer Susceptibility Allele with Enhanced Kinase Activity

Haris G. Vikis, Mitsuo Sato, Michael A. James et al. · Cancer Research · 2007 · 104 citations · Full text

RECIST 1.1 for Response Evaluation Apply Not Only to Chemotherapy-Treated Patients But Also to Targeted Cancer Agents: A Pooled Database Analysis

Saskia Litière, Gaëlle Isaac, Elisabeth G.E. de Vries et al. · Journal of Clinical Oncology · 2019 · 72 citations · Full text

Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis

Miaotian Cai, Min Zhu, Chengjun Ban et al. · Chinese Medical Journal · 2014 · 37 citations · Full text

A new ALK inhibitor overcomes resistance to first‐ and second‐generation inhibitors in NSCLC

Yue Lü, Zhenzhen Fan, Sujie Zhu et al. · EMBO Molecular Medicine · 2021 · 34 citations · Full text

Health Sciences, Medicine, New Alk Inhibitor +10

SPP1 overexpression is associated with poor outcomes in ALK fusion lung cancer patients without receiving targeted therapy

Xiaolin Ji, Yan Liu, Fang Mei et al. · Scientific Reports · 2021 · 33 citations · Full text

Tumor Biology, Alk Fusion, Gene Rearrangements +14